Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Saeed Hamid

Showing results (111-120 of 157) with videos related to

Pageof 16
Sort By:
Journal of Clinical Gastroenterology|November 20, 2025
Clinical Outcomes of Terlipressin Using Continuous Infusion Versus Bolus in Patients With Acute Variceal Hemorrhage-A Randomized Controlled TrialShahab Abid, Nazish Butt, Chaudary Qasim, et al.
American Journal of Obstetrics and Gynecology|July 3, 2024
Best practices for hepatitis C linkage to care in pregnant and postpartum women: perspectives from the Treatment In Pregnancy for Hepatitis C Community of PracticeNeil Gupta, Lindsey Hiebert, Ankeeta Saseetharran, et al.
Hepatology (Baltimore, Md.)|February 21, 2023
Treatment of chronic hepatitis D with peginterferon lambda-the phase 2 LIMT-1 clinical trialOhad Etzion, Saeed Hamid, Yoav Lurie, et al.
International Journal of Epidemiology|January 9, 2018
Curbing the hepatitis C virus epidemic in Pakistan: the impact of scaling up treatment and prevention for achieving eliminationAaron G Lim, Huma Qureshi, Hassan Mahmood, et al.
Inflammatory Bowel Diseases|August 15, 2020
Worldwide Management of Inflammatory Bowel Disease During the COVID-19 Pandemic: An International SurveyCharles N Bernstein, Siew C Ng, Rupa Banerjee, et al.
Journal of Hepatology|April 16, 2019
Treating chronic hepatitis delta: The need for surrogate markers of treatment efficacyCihan Yurdaydin, Zaigham Abbas, Maria Buti, et al.
BMC Public Health|December 19, 2023
HepFREEPak: protocol for a multi-centre, prospective observational study examining efficacy and impact of current therapies for the treatment of hepatitis C in Pakistan and reporting resistance to antiviral drugs: study protocolAmbreen Arif, Aliya Hasnain, Auj Chaudhry, et al.
Journal of Viral Hepatitis|March 28, 2024
Preferences and feasibility of long-acting technologies for treatment of hepatitis C virus in low- and middle-income countries: A survey of providers and policymakersNeil Gupta, Susan Swindells, Kimberly K Scarsi, et al.
Journal of Clinical Gastroenterology|November 24, 2020
WGO Guidance for the Care of Patients With COVID-19 and Liver DiseaseSaeed Hamid, Mario R Alvares da Silva, Kelly W Burak, et al.
Hepatology Communications|July 26, 2022
The impact of the COVID-19 pandemic on patients with chronic liver disease: Results from the Global Liver RegistryZobair M Younossi, Yusuf Yilmaz, Mohamed El-Kassas, et al.
Pageof 16

Showing results (111-120 of 157) with videos related to

Sort By:
Pageof 16
Journal of Clinical Gastroenterology|November 20, 2025
Clinical Outcomes of Terlipressin Using Continuous Infusion Versus Bolus in Patients With Acute Variceal Hemorrhage-A Randomized Controlled TrialShahab Abid, Nazish Butt, Chaudary Qasim, et al.
American Journal of Obstetrics and Gynecology|July 3, 2024
Best practices for hepatitis C linkage to care in pregnant and postpartum women: perspectives from the Treatment In Pregnancy for Hepatitis C Community of PracticeNeil Gupta, Lindsey Hiebert, Ankeeta Saseetharran, et al.
Hepatology (Baltimore, Md.)|February 21, 2023
Treatment of chronic hepatitis D with peginterferon lambda-the phase 2 LIMT-1 clinical trialOhad Etzion, Saeed Hamid, Yoav Lurie, et al.
International Journal of Epidemiology|January 9, 2018
Curbing the hepatitis C virus epidemic in Pakistan: the impact of scaling up treatment and prevention for achieving eliminationAaron G Lim, Huma Qureshi, Hassan Mahmood, et al.
Inflammatory Bowel Diseases|August 15, 2020
Worldwide Management of Inflammatory Bowel Disease During the COVID-19 Pandemic: An International SurveyCharles N Bernstein, Siew C Ng, Rupa Banerjee, et al.
Journal of Hepatology|April 16, 2019
Treating chronic hepatitis delta: The need for surrogate markers of treatment efficacyCihan Yurdaydin, Zaigham Abbas, Maria Buti, et al.
BMC Public Health|December 19, 2023
HepFREEPak: protocol for a multi-centre, prospective observational study examining efficacy and impact of current therapies for the treatment of hepatitis C in Pakistan and reporting resistance to antiviral drugs: study protocolAmbreen Arif, Aliya Hasnain, Auj Chaudhry, et al.
Journal of Viral Hepatitis|March 28, 2024
Preferences and feasibility of long-acting technologies for treatment of hepatitis C virus in low- and middle-income countries: A survey of providers and policymakersNeil Gupta, Susan Swindells, Kimberly K Scarsi, et al.
Journal of Clinical Gastroenterology|November 24, 2020
WGO Guidance for the Care of Patients With COVID-19 and Liver DiseaseSaeed Hamid, Mario R Alvares da Silva, Kelly W Burak, et al.
Hepatology Communications|July 26, 2022
The impact of the COVID-19 pandemic on patients with chronic liver disease: Results from the Global Liver RegistryZobair M Younossi, Yusuf Yilmaz, Mohamed El-Kassas, et al.
Pageof 16